Top Managed Healthcare Companies To Watch In Right Now

Top Managed Healthcare Companies To Watch In Right Now: Sequenom Inc.(SQNM)

Sequenom, Inc. provides products, services, diagnostic testing, applications, and genetic analysis products that translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural and livestock research. The company operates in two segments, Molecular Diagnostics and Genetic Analysis. The Molecular Diagnostics segment researches, develops, and commercializes noninvasive molecular diagnostic tests for prenatal genetic disorders and diseases, women?s health related disorders and diseases, ophthalmology, oncology, infectious diseases, and autoimmunity. This segment markets diagnostic technology for prenatal diagnostics under the trademark SEQureDx. The Genetic Analysis segment designs and markets MassARRAY system, a nucleic acid analysis platform that comprises hardware, software applications, consumable chips, and reagents to measure genetic target material and variations. This segment o ffers its MassARRAY system for various DNA/RNA analysis applications, including single nucleotide polymorphism (SNP), genotyping, detection of mutations, analysis of copy number variants, and other structural genome variations, as well as quantitative gene expression analysis, quantitative methylation marker analysis, comparative sequence analysis of haploid organisms, SNP discovery, and oligonucleotide quality control. It also provides iPLEX multiplexing assay, which permits multiplexed SNP analysis and somatic mutation analysis. The company offers its products through direct sales, and sales and distribution partners to clinical research laboratories, bio-agriculture, bio-technology and pharmaceutical companies, academic institutions, and various government agencies worldwide. Sequenom, Inc. was founded in 1994 and is headquartered in San Diego, California.

Advisors' Opinion:

• [By Keith Speights]

  The check wasn'! t in the mail
  Genetic analysis solutions provider Sequenom (NASDAQ: SQNM  ) announced its second-quarter financial results this week. Mr. Market wasn't happy. Shares plunged nearly 30% for the week.

• [By Keith Speights]

  Top line makes everything fine
  Sequenom (NASDAQ: SQNM  ) lost more money in the first quarter than it did in the same period last year. The life-sciences company also missed the average analyst earnings estimate. Did shares fall? Nope -- they jumped 14%.

• [By Dan Carroll]

  Vertex couldn't stack up with biotech's big loser this week, Sequenom (NASDAQ: SQNM  ) , whose shares lost a painful 29.8% this week after the company reported an intensifying second-quarter loss in its earnings report. Earnings aren't always a big deal for smaller biotechs, but a reimbursement delay caused by billing code changes from the Centers for Medicare and Medicaid Services around Sequenom's MaterniT21 chromosomal diagnostic test sparked a rash of downgrades from across Wall Street.

• [By Paul Ausick]

  Stocks on the Move: ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA) is down 44.4% at $2.20 after suspending sales of a cancer drug. Alcatel-Lucent (NYSE: ALU) is up 16.4% at $3.84 as investors remain patient with the companys turnaround plan. 58.com Inc. (NYSE: WUBA) is up 43.1% at $24.32 after todays IPO. Sequenom Inc. (NASDAQ: SQNM) is down 22.6% at $1.92 after court rules a patent invalid.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/top-managed-healthcare-companies-to-watch-in-right-now-2.html